tetano
Editor, Senior Moderator
Int J Biol Macromol
. 2022 Jan 19;S0141-8130(22)00123-4.
doi: 10.1016/j.ijbiomac.2022.01.108. Online ahead of print.
Review: A systematic review of virus-like particles of coronavirus: Assembly, generation, chimerism and their application in basic research and in the clinic
Wan Lu[SUP] 1 [/SUP], Zhuangzhuang Zhao[SUP] 1 [/SUP], Yao-Wei Huang[SUP] 2 [/SUP], Bin Wang[SUP] 3 [/SUP]
Affiliations
Abstract
Virus-like particles (VLPs) are nano-scale particles that are morphologically similar to a live virus but which lack a genetic component. Since the pandemic spread of COVID-19, much focus has been placed on coronavirus (CoV)-related VLPs. CoVs contain four structural proteins, though the minimum requirement for VLP formation differs among virus species. CoV VLPs are commonly produced in mammalian and insect cell systems, sometimes in the form of chimeric VLPs that enable surface display of CoV epitopes. VLPs are an ideal model for virological research and have been applied as vaccines and diagnostic reagents to aid in clinical disease control. This review summarizes and updates the research progress on the characteristics of VLPs from different known CoVs, mainly focusing on assembly, in vitro expression systems for VLP generation, VLP chimerism, protein-based nanoparticles and their applications in basic research and clinical settings, which may aid in development of novel VLP vaccines against emerging coronavirus diseases such as SARS-CoV-2.
Keywords: Coronavirus (CoV); Expression system; Vaccine; Virus-like particles (VLPs).
. 2022 Jan 19;S0141-8130(22)00123-4.
doi: 10.1016/j.ijbiomac.2022.01.108. Online ahead of print.
Review: A systematic review of virus-like particles of coronavirus: Assembly, generation, chimerism and their application in basic research and in the clinic
Wan Lu[SUP] 1 [/SUP], Zhuangzhuang Zhao[SUP] 1 [/SUP], Yao-Wei Huang[SUP] 2 [/SUP], Bin Wang[SUP] 3 [/SUP]
Affiliations
- PMID: 35065135
- DOI: 10.1016/j.ijbiomac.2022.01.108
Abstract
Virus-like particles (VLPs) are nano-scale particles that are morphologically similar to a live virus but which lack a genetic component. Since the pandemic spread of COVID-19, much focus has been placed on coronavirus (CoV)-related VLPs. CoVs contain four structural proteins, though the minimum requirement for VLP formation differs among virus species. CoV VLPs are commonly produced in mammalian and insect cell systems, sometimes in the form of chimeric VLPs that enable surface display of CoV epitopes. VLPs are an ideal model for virological research and have been applied as vaccines and diagnostic reagents to aid in clinical disease control. This review summarizes and updates the research progress on the characteristics of VLPs from different known CoVs, mainly focusing on assembly, in vitro expression systems for VLP generation, VLP chimerism, protein-based nanoparticles and their applications in basic research and clinical settings, which may aid in development of novel VLP vaccines against emerging coronavirus diseases such as SARS-CoV-2.
Keywords: Coronavirus (CoV); Expression system; Vaccine; Virus-like particles (VLPs).